CFDB - Cystic Fibrosis DataBase

at least one term
all terms
All subcategories » trial from www.clinicaltrials.gov

Is telehealth as effective as face to face therapy for delivery of whole body vibration training (WBVT) as an adjunct to physiotherapy in children and young people with cystic fibrosis (CF)?

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2019
  • Alexander E

Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: a randomized multicenter study

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2019
  • Dolce D

Stability of serum precipitins to Aspergillus fumigatus for the diagnosis of allergic bronchopulmonary aspergillosis

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2019
  • Lau KSK

Inhaled dry powder alginate oligosaccharide (OligoG) in cystic fibrosis: sub-group analyses of a double-blind, randomized, placebo-controlled, efficacy and safety trial

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2019
  • Rye P

A prospective mixed-methods pilot study assessing the effects of improving diabetes education in adults with cystic fibrosis (IDEA-CF)

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2019
  • Sunsoa HK

Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2025

Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2025

Study With Phage for CF Subjects With Pseudomonas Lung Infection

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2025

The Effect of Probiotic Consumption on Improving the Quality of Life in Children Aged 6 to 13 Years with Cystic Fibrosis (CF) - Pending

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2025

A randomised, double-blind, placebo controlled, two-part study to evaluate the efficacy, safety, tolerability and pharmacokinetics of a repeat dose of inhaled ETD001 in people with cystic fibrosis - Ongoing

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2024